Young-onset Parkinson disease: genes and variants
Explore variant evidence for Young-onset Parkinson disease across 9 analyzed proteins (PRKN, PARK7, VPS13C, LRRK2, SYNJ1 and 4 more). Linked ClinVar records include 6 pathogenic or likely pathogenic variants, 0 variants of uncertain significance and 2 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-04. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Young-onset Parkinson disease
PRKN: E3 ubiquitin-protein ligase parkin
Its parkin ubiquitin-ligase activity marks damaged mitochondrial proteins after PINK1 activation and helps eliminate dysfunctional mitochondria through mitophagy. Biallelic loss-of-function variants are a major cause of autosomal recessive juvenile or early-onset Parkinson disease.
2 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in PRKN have source records linked to Young-onset Parkinson disease. Association strength is not clinical gene validity.
PARK7: Parkinson disease protein 7
It supports mitochondrial quality control, redox homeostasis, and cellular responses to oxidative stress. Biallelic loss-of-function variants cause a rare autosomal recessive form of early-onset Parkinson disease.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in PARK7 have source records linked to Young-onset Parkinson disease. Association strength is not clinical gene validity.
VPS13C: Intermembrane lipid transfer protein VPS13C
It forms a long bridge-like channel that transfers lipids between membranes at organelle contact sites, including those involving the endoplasmic reticulum and lysosomes. It supports organelle membrane homeostasis and mitochondrial health, and biallelic loss-of-function variants cause early-onset autosomal recessive Parkinson disease.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in VPS13C have source records linked to Young-onset Parkinson disease. Association strength is not clinical gene validity.
LRRK2: Leucine-rich repeat serine/threonine-protein kinase 2
Its kinase and GTPase activities regulate Rab proteins, vesicle trafficking, lysosomal function, and cellular stress responses. Gain-of-function variants, especially G2019S, are among the most common genetic causes of autosomal dominant Parkinson disease.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in LRRK2 have source records linked to Young-onset Parkinson disease. Association strength is not clinical gene validity.
SYNJ1: Polyphosphatidylinositol phosphatase SYNJ1
It remodels phosphoinositides during clathrin-mediated synaptic-vesicle recycling and helps nerve terminals rapidly regenerate release-ready vesicles. Biallelic pathogenic variants can cause early-onset parkinsonism or severe developmental and epileptic encephalopathy.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SYNJ1 have source records linked to Young-onset Parkinson disease. Association strength is not clinical gene validity.
PINK1: Serine/threonine-protein kinase PINK1, mitochondrial
It accumulates on damaged mitochondria and recruits parkin to initiate selective mitophagy and mitochondrial quality control. Biallelic loss-of-function variants cause autosomal recessive early-onset Parkinson disease.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in PINK1 have source records linked to Young-onset Parkinson disease. Association strength is not clinical gene validity.
DNAJC6: Auxilin
It recruits HSC70 to clathrin-coated vesicles and promotes uncoating during synaptic-vesicle recycling. Biallelic pathogenic variants can cause severe juvenile parkinsonism with developmental and other neurologic abnormalities.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in DNAJC6 have source records linked to Young-onset Parkinson disease. Association strength is not clinical gene validity.
SNCA: Alpha-synuclein
Alpha-synuclein is a neuronal protein that supports synaptic-vesicle trafficking, priming, and neurotransmitter release. Misfolded or aggregated alpha-synuclein is a defining feature of Parkinson disease and Lewy-body disorders.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SNCA have source records linked to Young-onset Parkinson disease. Association strength is not clinical gene validity.
VPS35: Vacuolar protein sorting-associated protein 35
It helps retromer complexes retrieve selected cargo from endosomes for recycling to the Golgi or cell surface instead of lysosomal degradation. The p.Asp620Asn variant causes autosomal dominant Parkinson disease and links impaired endosomal trafficking to neurodegeneration.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in VPS35 have source records linked to Young-onset Parkinson disease. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Young-onset Parkinson disease
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SYNJ1 R219Q | 219 | SAC | Pathogenic / likely pathogenic (★★★★) |
| LRRK2 G2019S | 2019 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| PRKN G430D | 430 | RING-type 2 | Pathogenic / likely pathogenic (★★) |
| PRKN R275W | 275 | RING-type 1 | Pathogenic / likely pathogenic (★★) |
| VPS13C G1389R | 1389 | Pathogenic / likely pathogenic (★★) | |
| PARK7 T154A | 154 | Pathogenic / likely pathogenic (★) |
Uncertain variants prioritized for review in Young-onset Parkinson disease
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| PRKN G430S | 430 | RING-type 2 | Conflicting reports (★) | +7: G430D at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.944 |
Same protein, different disease
- Autosomal recessive juvenile Parkinson disease 2 also has ClinVar records linked to PRKN variants; they fall mostly in different places as the Young-onset Parkinson disease variants (15 pathogenic / likely pathogenic).
- Ovarian cancer also has ClinVar records linked to PRKN variants; they fall mostly in different places as the Young-onset Parkinson disease variants (5 pathogenic / likely pathogenic).
- Lung cancer also has ClinVar records linked to PRKN variants; they fall mostly in different places as the Young-onset Parkinson disease variants (4 pathogenic / likely pathogenic).
- Autosomal recessive early-onset Parkinson disease also has ClinVar records linked to PARK7 variants; they fall mostly in different places as the Young-onset Parkinson disease variants (7 pathogenic / likely pathogenic).
- Autosomal dominant Parkinson disease also has ClinVar records linked to LRRK2 variants; they fall mostly in different places as the Young-onset Parkinson disease variants (7 pathogenic / likely pathogenic).
Diseases related to Young-onset Parkinson disease
- Parkinson disease, also linked to DNAJC6, LRRK2, PARK7, PINK1 and 5 more
- Autosomal recessive early-onset Parkinson disease, also linked to PARK7, PINK1 and VPS13C
- Autosomal dominant Parkinson disease, also linked to LRRK2, PRKN and SNCA
- Developmental and epileptic encephalopathy, also linked to SYNJ1
- Ovarian cancer, also linked to PRKN
- Autosomal recessive juvenile Parkinson disease 2, also linked to PRKN
- Ovarian neoplasm, also linked to PRKN
- Lung cancer, also linked to PRKN
- Lewy body dementia, also linked to SNCA
- Genetic developmental and epileptic encephalopathy, also linked to SYNJ1
Frequently asked questions
Which genes have records linked to Young-onset Parkinson disease?
This view contains 9 analyzed proteins: PRKN, PARK7, VPS13C, LRRK2, SYNJ1 and 4 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 6 pathogenic or likely pathogenic variants, 0 variants of uncertain significance and 2 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 256 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center